Overall, sustained innovation, favorable reimbursement, and rising health awareness are expected to reinforce long-term market growth
Science 309 , 18291833 (2005)
Votre mdecin adaptera les posologies pour limiter le risque d'hypoglycmie
By maintaining a healthy weight, you may be able to lower these risks and avoid obesity-related gynecologic issues later in life
Not just chemistry, but biology, precision design, and regulatory depth are now becoming essential to compete in this space." Hari Kiran Chereddi, MD & CEO, HRV Pharma and NHG Pharma GLP-1 Patent Expiry Timeline and Market Dynamics The market opportunity is defined by several critical factors: Patent Expiration: Semaglutide's key patents expire globally by early 2026 Market Growth: Demand for obesity and diabetes treatments growing 12-14% year-over-year Healthcare Savings: Indian companies can save global healthcare systems billions through cost-effective alternatives Regulatory Access: Opportunities to develop biosimilars or complex generics for US and EU markets Beyond Cost Competition: Value-Based Differentiation The competitive landscape for GLP-1 drugs extends beyond traditional cost advantages that have historically defined Indian pharmaceutical success
We consider Wisp to be overpriced based on this analysis
%20(1).png)
